The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 70,818 |
| Depreciation and amortization | 187,559 |
| Other amortization | 37,640 |
| Deferred rent | -3,079 |
| Stock based compensation | 14,621 |
| Loss (gain) on dispositions of real estate investments, net | -2,965 |
| Impairment of real estate investments | 49,935 |
| Impairment of intangible assets | 0 |
| Loss from unconsolidated entities | -1,967 |
| Distributions of earnings from unconsolidated entity | 211 |
| Deferred income taxes | -22,939 |
| Gain on re-measurement of previously held equity interests | 14,580 |
| Foreign currency (gain) loss | 3,219 |
| Loss on extinguishments of debt | -1,830 |
| Change in fair value of derivative financial instruments | -1,034 |
| Accounts and other receivables | 13,050 |
| Other assets | 20,635 |
| Accounts payable and accrued liabilities | 29,013 |
| Operating lease liabilities | 30,038 |
| Security deposits, prepaid rent and other liabilities | -4,388 |
| Net cash provided by operating activities | 294,441 |
| Developments and capital expenditures | 128,562 |
| Acquisitions of real estate investments | 884,425 |
| Proceeds from dispositions of real estate investments | 50,213 |
| Acquisitions of previously held equity interests | 118,398 |
| Investments in unconsolidated entities | 443 |
| Distributions in excess of earnings from unconsolidated entity | 0 |
| Issuances of real estate notes receivable | 5,855 |
| Principal repayments on real estate notes receivable | 10,788 |
| Real estate and other deposits | 6,610 |
| Net cash (used in) provided by investing activities | -1,083,292 |
| Borrowings under mortgage loans payable | 30,000 |
| Payments on mortgage loans payable | 49,159 |
| Borrowings under the lines of credit and term loan | 248,500 |
| Payments on the lines of credit and term loan | 387,532 |
| Borrowings under financing obligations | 0 |
| Payments on financing and other obligations | 1,750 |
| Deferred financing costs | 513 |
| Debt extinguishment costs | 150 |
| Proceeds from issuance of common stock in offerings | 1,156,273 |
| Proceeds from issuance of common stock pursuant to employee stock purchase plan | 238 |
| Payment of offering costs | 10,057 |
| Distributions paid | 163,522 |
| Repurchase of common stock | 0 |
| Payments to taxing authorities in connection with common stock directly withheld from employees | 2,402 |
| Purchase of noncontrolling interests | 0 |
| Distributions to noncontrolling interests | 2,429 |
| Redemptions of noncontrolling interests | 0 |
| Security deposits, net | -256 |
| Net cash provided by (used in) financing activities | 817,241 |
| Net change in cash, cash equivalents and restricted cash | 28,390 |
| Effect of foreign currency translation on cash, cash equivalents and restricted cash | 62 |
| Cash, cash equivalents and restricted cash beginning of period | 123,301 |
| Cash, cash equivalents and restricted cash end of period | 151,753 |
American Healthcare REIT, Inc. (AHR)
American Healthcare REIT, Inc. (AHR)